Multiple Sclerosis, Rituximab, Hypogammaglobu...

Up next

Trends in Emergent Interfacility Ischemic Stroke Transfers

Dr. Andy Southerland talks with Dr. Matthew Gusler about trends in emergent interfacility transfers for ischemic stroke and factors associated with transfer for care. Read the related article in Neurology®. Disclosures can be found at Neurology.org.

. 15min 40sec

Clinical Reasoning: Rapidly Progressive Cranial Neuropathies, Weakness, and Ataxia in a Patient With MS

Dr. Zohaib Siddiqi talks with Dr. Michel Toledano about the diagnosis and management of infectious rhombencephalitis in patients receiving immunomodulatory therapy. Read the related Resident & Fellow Section article in Neurology®. Disclosures can be found at Neurology.org.

. 25min 42sec

Recommended Episodes

Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections

Neurology Minute

Dr. Shuvro Roy and Dr. Annette Langer-Gould discuss the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks. Show reference: https://www.neurology.org/doi/10.1212/NXI.0 ... Show more

. 4min 4sec

Impact of Immune Checkpoint Inhibitors

Neurology Minute

Drs. Justin Abbatemarco and Géraldine Androdias discuss the impact of immune checkpoint inhibitors on the course of multiple sclerosis. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200202 This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for ... Show more

. 2min 8sec

Safety and Efficacy of Satralizumab in Patients with Generalized MG

Neurology Minute

Dr. Justin Abbatemarco and Dr. Aaron Zelikovich discuss the safety and efficacy of satralizumab and its role in the current treatment landscape for myasthenia gravis. Show reference: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00514-3/fulltext

. 4min 6sec